EW TECHNIQUE OF REGIONAL ANALGESIA TO REDUCE PAIN AFTER BREAST SURGERY
Phase 4
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2021/03/031731
- Lead Sponsor
- IL RATAN SIRCAR MEDICAL COLLEGE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
FEMALE PATIENTS WITH CARCINOMA OF BREAST POSTED FOR MODIFIED RADICAL MASTECTOMY OPERATIO
Exclusion Criteria
PATIENT REFUSAL
ASA PHYSICAL STATUS 3 OR MORE
BODY MASS INDEX MORE THAN 35
LOCAL SITE INFECTION
DRUG ALLERGY
BLEEDING DISORDER
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method DURATION OF POST OPERATIVE ANALGESIATimepoint: 0, 1/2, 2, 4, 6, 8, 12 , 24 HOURS
- Secondary Outcome Measures
Name Time Method TOTAL OPIOID REQUIREMENT FOR POST OPERATIVE ANALGESIATimepoint: 24 HOURS
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms mediate erector spinae plane block (ESPB) analgesic effects in post-mastectomy pain management?
How does erector spinae plane block (ESPB) compare to paravertebral blocks in post-operative pain scores after modified radical mastectomy?
Which biomarkers correlate with successful erector spinae plane block (ESPB) outcomes in breast cancer patients undergoing surgery?
What are the safety profiles and management strategies for complications associated with ESPB in CTRI/2021/03/031731?
What adjuvant drugs or alternative regional analgesia techniques synergize with ESPB for enhanced post-mastectomy pain relief?